p. 40, line 5: I would say "one" instead of "either" The authors report that mice lacking phosphatidic acid-selective phospholipase A1 display hair follicle derangements resembling the wavy hair phenotype of mice defective in the EGFR pathway or TACE. These mice display less soluble TGF and EGFR phosphorylation. Moreover, they showed that in keratinocytes stimulation with LPA or P2Y5 agonists induced EGFR transactivation via MMP-mediated TGF release. The authors state that the PA-PLA1 -LPA-P2Y5 signaling pathway controls hair follicle formation by inducing the release of TGF and subsequent EGFR transactivation, and that 2-acyl-LPA is specific for hair follicle formation.
The experiments described in the manuscript are well performed and reveal an interesting function of the PA-PLA1 -LPA-P2Y5 signaling pathway during hair follicle formation. However, the proposed mechanism involving MMPs (and possibly TACE) has not really been demonstrated and should be addressed before considering publication in EMBO J.
Specific points:
1. Is TACE expression/activity decreased in PA-PLA1 -/-mice? What about other metalloproteinases? The authors should mechanistically work out which protease is responsible for TGF cleavage in response to LPA/P2Y5.
Does LPA administration induce the release of other EGFR ligands besides TGF ?
3. Is the phosphorylation status of EGFR altered in situ in hair follicles from PA-PLA1 -/-mice? Is P2Y5 expressed in the same cells?
4. Figure 5C : Why does LPA at 1µM induce EGFR phosphorylation in the presence of MMP inhibitors? The statement "LPA also induced a dramatic increase in the level of phosphorylated EGFR at Tyr1068 (p-EGFR)" is exaggerated.
5. Figure 4B : The statement "Among eight LPA species examined, five of six unsaturated LPA species (18:2, 18:1, 20:5, 20:4 and 22:6) were decreased in PA-PLA1 -/-mice, whereas saturated LPA species (16:0 and 18:0) were unchanged" is incorrect as LPA 16:0 is also significantly decreased in PA-PLA1 -/-mice.
6. The labelling in Fig. 3B ,C and S3A and the respective text is wrong. The phase until postnatal day 14 is not Anagen as indicated but hair follicle morphogenesis. The first hair cycle starts with Catagen! 7. Statistical analysis is missing in Fig. S4 Referee #3 (Remarks to the Author):
In this manuscript the authors generate a full knockout mouse of the PA-PLA1 gene, an enzyme that is important in phospholipid synthesis, which was previously known to trigger TGF and eventually EGFR activation. In characterizing the full knockout phenotype the authors observed a mild hair follicle defect, which they characterize as an impaired inner root sheath formation, with defect in hair shaft molding. This is the most novel part of the paper, but the phenotype has not been sufficiently documented to make it compelling data. The authors form of presentation suggests that this would be of general interest to a broader Biology audience because of the connection with a human hair defect, although this knockout demonstrated that the gene of interest is not the major player in the patients phenotype-who actually loose their hair. The authors then go on to examine the mechanisms of action for this gene in vitro, in keratinocytes, and confirm its activity in generating species of phospholipids that can in turn release TGFa and activate EGFR. Many facts in this model are not novel and as cited by the authors has been documented in other in vitro systems.
There is a large body of data here examining the details of phospho-lipid species generation and activity that seems highly specialized and in my opinion would be likely more suitable for publication in a different journal, while focusing the experiments more for this EMBO manuscript.
Major experimental criticism: 1. The curly hair phenotype was not documented convincingly, although data in Figure 2B&C show clear defects in the molding of the hair shaft. Figure S2A , S2C and 1A not convincing-maybe move S2B in Figure 1A next to the mice. How many mice and hair follicle have been analyzed? In general the number of experiments were not stated throughout the paper. 2. Where exactly is the PA-PLA1alpha gene expressed in the hair follicle epithelial cells? The mRNA in situ is not necessarily convincing. Can the authors perform antibody staining and colocalization of with other hair markers in wild type and knockout mice? 3. In figure 1 -the authors should add immunofluorescence staining for the IRS-the defects in IRS are not clear and the H&E although suggesting does not provide sufficient information to document the phenotype-4. When referring to "expression Pattern" on page 9 of the P2Y5, TGFalpha, EGFR and AP_PLA1a, the authors mean "expression level at different stages". The paper lacks patterns of expression in the real sense given by in situ analysis by immunostaining, to demonstrate that these factors are expressed in the same cell types -although this was studied somewhere else, it will add to the paper to do it here especially since this is the first time when a PA-PLA antibody staining can be performed with the appropriate control meaning using the knockout skin(since the knockout has been established here) 5. The major conclusion is that the activation of EGFR via LPA and PA-PLA1a leads to hair follicle formation-but the hair follicles did form in the knockout mice, they just show some mild defects in the hair shaft appearance. I would change the title to reflect the defect in the IRS -maybe use instead of "formation" "proper hair follicle differentiation", or something about the hair shaft molding. Impaired "formation" would mean the entire hair follicles with bulges and bulbs were missing from the dermis. Minor criticism 1. In the intro it is mentioned PA-PLA is high in hair follicle epithelial cells without a reference. 2. The abstract and intro should mention that the PA-PLA1 knockout mice have been generated here in this study-this is fair to the paper and makes it clear what the contribution is. 3. Data in S1C shows western with extract from stomachs-why not skin? 4. "Conditioned" in figure 6A is misspelled; 5. The scheme in Figure 6A is nice. Something similar should be added to Figure 1 to introduce the phospholipid system for the general audience at EMBO.
Resubmission 28 April 2011
Tracking number EMBOJ-2010-75294 (Inoue et al., " LPA-producing enzyme PA-PLA1 regulates hair follicle development by modulating EGFR signaling" in the revised title, "TGF release and EGFR transactivation underlie lysophosphatidic acid-induced hair follicle formation" in the original title).
Thank you very much for your e-mail dated on August 12, 2010, with respect to our above manuscript. We are much pleased to know that the Referees have appreciated our work. Although the first manuscript was returned, the Referees' comments were very helpful for us. According to the suggestions of the Referees' comments, we performed additional experiments and we believe that we can now meet all of the Referees' comments and suggestions. Especially, we could demonstrate that the protease responsible for TGF cleavage was TACE and that PA-PLA1 was colocalized with TACE, TGF and p-EGFR in the specific layer, called the inner root sheath, of the hair follicle. Thus, we could clearly show that a PA-PLA1 -LPA-P2Y5 pathway regulates TACE-TGF -EGFR signaling in hair follicle development. Our current works are innovative studies from the view of the first in vivo evidence for LPA-induced EGFR transactivation. Therefore, we hope that our studies now meet the scientific criteria of the EMBO Journal and we hope that you would consider the re-review of our work as a revised manuscript in the EMBO Journal.
For your convenience, we added our point-by-point responses to the specific comments raised by the three Referees.
(Note that all figures and page numbers refer to the revised manuscript otherwise mentioned.)
Referee #1: As suggested by the Referee #1, we have repeatedly examined the TGF levels in the soluble fraction of hair follicles by carefully isolating vibrissa hair follicles using ADAM inhibitors. We found that soluble TGF level in PA-PLA1 -/-mice was approximately one third of that in WT mice ( Figure 5A ). We further performed immunofluorescent staining of p-EGFR in hair follicles. We found that p-EGFR was specifically localized to the IRS in hair follicles and that the p-EGFR level was dramatically decreased in PA-PLA1 -/-mice ( Figure 5D ). Thus, we can now show that the decrease in TGF ectodomain shedding actually occurs in PA-PLA1 -/-hair follicles. According to the Referee #1's recommendation, we have determined the amount of TGF in the insoluble fraction of hair follicle lysates. We found that the amount of the cellassociated/membrane-bound form of TGF in the PA-PLA1 -/-sample was almost equal to that in WT sample (Supplementary Figure S6B) . A previous report showed that the compound SDZ 242-484 inhibited the activity of TACE as well as those of MMPs (MMP-1, MMP-2 and MMP-3) at IC50 values of sub nM range in vitro (Kottirsch et al., J. Med. Chem. 45, 2289 (2002 , this reference was included in the revised manuscript (p. 10, line 19 etc.). To examine a proteinase involved in LPA-induced ectodomain shedding of TGF , we focused on TACE and performed siRNA-mediated knockdown of TACE because TACE was shown to be involved in hair follicle development and ectodomain shedding of TGF (Peschon et al., Science 282, 1281 -1284 (1998 ). Transfection of TACE siRNA completely abolished LPA-induced TGF release in both HaCaT human keratinocytes and HEK293 cells ( Figure 6F and 7F), which mimicked SDZ 242-484 treatment ( Figure 6A and 7G). Thus we concluded that TACE is responsible for LPA-induced TGF shedding and is inhibited by SDZ 242-484. We observed that presence of SDZ 242-484 at the same concentration (10 µM) used in the TGF release assay ( Figure 6A ) did not affect EGF-induced phosphorylation of EGFR and ERK in HaCaT cells ( Figure 6C ). This indicates that the effect of SDZ 242-484 on TGF release is not likely due to cytotoxicity.
A related (but less fundamental) weakness, in the in
3 Figure 1B shows appearance of P25 mice. To avoid confusion, "One week after birth" was deleted.
Instead, "The wavy hair phenotype was most apparent from one to four weeks of age and became less severe after the start of the anagen (growth) phase of the first hair cycle." was added (p. 5, line 14). p. 14, line 3: meaning of "emerging" here isn't clear As pointed out by the Referee #1's comment, we have deleted the word "emerging" (p. 14, line 5).
p. 14, line 10: "significantly" suggests a lot, whereas in fact the differences are marginal; I would just say "decreased" As pointed out by the Referee #1's comment, we have deleted the word "significantly" (p. 14, line 12).
p. 15, line 4 from bottom: is the result with conditioned media shown?
We did not show the result with conditioned media. Thus we have included "data not shown" after "but not the conditioned media from the cells" (p. 16, line 1).
p. 16, line 5: insert "other" between "unlike" and "lipases" As pointed out by the Referee #1's comment, we have corrected the sentence (p. 16, line 11).
p. 37: isn't 10 µM an unphysiologically high concentration?
As the Referee #1 noted, 10 µM of LPA in the conditioned media seems to be an unphysiologically high concentration. However, from LC-MS/MS analysis (Figure 2A ), we estimated that one mouse vibrissa hair follicle contained approximately 0.12 pmol LPA which was produced by PA-PLA1 . Volume of mouse vibrissa hair follicle is approximately 0.6 mm3 (0.2 x 0.2 x 1.5 mm). Morphologically, the ratio of IRS volume to hair follicle is at most one fifth (see Supplementary Figure S4 ). We estimated that extracellular space is at most one tenth of total IRS volume (IRS is packed with cells). Taken together, concentration of LPA in IRS can be speculated around 10 µM (0.12 pmol / 0.6 mm3 x 5 x 10). We also note that more than 10 µM of LPA can be detected in serum and incubated plasma (Aoki et al., J. Biol. Chem. 277, 48737 (2002) ).
p. 40, line 5: I would say "one" instead of "either"
Thank you very much for the Referee #1's comment. In the preparation of the revised manuscript, we have deleted the sentence. (2008)). We found that there were no differences in the expression of eight ADAM members between WT and PA-PLA1 -/-hair follicles (Supplementary Figure S6C) . We also performed immunofluorescent staining of TACE in hair follicles. This analysis also showed no apparent difference between WT and PA-PLA1 -/-hair follicles (Supplementary Figure S7A) . Among ADAM members, wavy hair phenotype is observed only in TACE-deficient mice. In addition, TGF was shown to be a substrate for TACE (Edwards et al., Mol. Aspects Med. 29, 258 (2008) ). Thus, we focused on TACE and performed siRNA-mediated knockdown of TACE. Transfection of TACE siRNA completely abolished LPA-induced TGF release in both HaCaT human keratinocytes and HEK293 cells ( Figure 6F and 7F). Thus we concluded that TACE is responsible for TGF cleavage in response to LPA.
Does LPA administration induce the release of other EGFR ligands besides TGFa
We have examined release of other EGFR ligands (heparin-binding EGF-like growth factor (HB-EGF) and Amphiregulin). We transfected one of alkaline-phosphatase-tagged EGFR ligands ( Figure S10A ). Thus we concluded that LPA/P2Y5-induced EGFR ligand release is specific to TGF .
Is the phosphorylation status of EGFR altered in situ in hair follicles from PA-PLA1a-/-mice? Is P2Y5 expressed in the same cells?
We examined phosphorylation status of EGFR (p-EGFR) in hair follicles by immunofluorescence using antibody which specifically recognizes p-Tyr 1068 of EGFR. We found that (i) p-EGFR signal was significantly decreased in PA-PLA1 -/-hair follicle than WT hair follicle ( Figure 5D ) and (ii) p-EGFR was co-localized with PA-PLA1 ( Figure 4C ) and K72 (IRS marker; Figure 5D ). Expression of P2Y5 was demonstrated in a previous report (Shimomura et al., Nat. Genet. 40, 335 (2008)) showing that P2Y5 was exclusively expressed in the IRS. Thus, LPA-producing enzyme (PA-PLA1 ), LPA receptor (P2Y5) and p-EGFR are co-localized in the IRS. This strongly suggests that LPAinduced shedding of TGF and the following EGFR activation occur in the IRS.
Figure 5C: Why does LPA at 1 µM induce EGFR phosphorylation in the presence of MMP inhibitors? The statement "LPA also induced a dramatic increase in the level of phosphorylated EGFR at Tyr1068 (p-EGFR)" is exaggerated.
As pointed out by the Referee #2, it seems that 1 µM LPA in the presence of MMP inhibitor did not completely inhibited LPA-induced phosphorylation of EGFR. We repeated same experiments in three times and found that MMP inhibitor attenuated LPA-induced phosphorylation of EGFR. We replaced the previous image with another representative image ( Figure 6C ). As pointed out by the Referee #2, LPA-induced phosphorylation of EGFR was significant, but small as compared with EGF stimulation. Thus we have deleted the word "dramatic" from the sentence (p. 10, line 1 from bottom).
Figure 4B:
The statement "Among eight LPA species examined, five of six unsaturated LPA species (18:2, 18:1, 20:5, 20:4 and 22:6) were decreased in PA-PLA1a-/-mice, whereas saturated LPA species (16:0 and 18:0) were unchanged" is incorrect as LPA 16:0 is also significantly decreased in PA-PLA1a-/-mice.
As pointed out by the Referee #2, we have corrected the sentence. In the revised manuscript, we described "Among eight LPA species examined, five of six unsaturated LPA species (18:2, 18:1, 20:5, 20:4 and 22:6) were significantly reduced in both skin and hair follicles of PA-PLA1 -/-mice ( Figure 2A and Supplementary Figure S3B) . Notably, in hair follicle of PA-PLA1 -/-mice, the six unsaturated LPA species were reduced by more than 90%, whereas saturated LPA species were unchanged (18:0) or slightly decreased (16:0) ( Figure 2A )." (p. 6, line 10).
The labelling in Fig. 3B,C and S3A and the respective text is wrong. The phase until postnatal day 14 is not Anagen as indicated but hair follicle morphogenesis. The first hair cycle starts with Catagen!
As pointed out by the Referee #2, we misunderstood that hair follicle morphogenesis is the first hair cycle. In the revised manuscript, we have carefully checked words and used the word "morphogenesis" (legend of the Figure 4F etc.).
Statistical analysis is missing in Fig. S4
As pointed out by the Referee #2, we have included statistical analysis (Supplementary Figure S2 ).
Referee #3 (Remarks to the Author):
Major criticism Figure 2B&C show clear defects in the molding of the hair shaft. Figure S2A , S2C and 1A not convincing-maybe move S2B in Figure 1A next to the mice. How many mice and hair follicle have been analyzed? In general the number of experiments were not stated throughout the paper.
The curly hair phenotype was not documented convincingly, although data in
We have obtained more than three hundreds of PA-PLA1 -/-mice so far and all of them showed wavy hair phenotype. Thus, we have included the sentence "The hair abnormalities were observed in all PA-PLA1 -/-mice (more than 300 animals observed), …" in the revised manuscript (p. 5, line 11). In case of serial sections stained with HE, three pairs of littermates (at least four vibrissa hair follicles per an individual mouse) were examined and irregular IRS morphology was only observed in PA-PLA1 -/-hair follicles. For other cases, numbers of animals or numbers of independent analyses were written in the legends. According to the Referee #3's suggestion, we have moved the original Figure S2B showing wavy hair in Figure 1 (the image is numbered as Figure 1D ).
Where exactly is the PA-PLA1alpha gene expressed in the hair follicle epithelial cells? The mRNA in situ is not necessarily convincing. Can the authors perform antibody staining and colocalization of with other hair markers in wild type and knockout mice?
We performed immunofluorescent staining of PA-PLA1 using enhanced sensitivity method (TSA system kit, Invitrogen) and successfully detected PA-PLA1 protein in hair follicles ( Figure 3F ). Among layer-specific markers, PA-PLA1 was co-localized with the IRS marker (K72) and the companion layer marker (K75) ( Figure 3G and H). It should be noted that PA-PLA1 was not colocalized with Trichohyalin ( Figure 3G ), showing that PA-PLA1 was expressed in IRS cuticle, not in the Huxley's layer, of the IRS (also see Figure 3E ).
In figure 1 -the authors should add immunofluorescence staining for the IRS-the defects in IRS are not clear and the H&E although suggesting does not provide sufficient information to document the phenotype-
According to the suggestion of the Referee #3, we performed immunofluorescent staining for IRS using antibodies against K72 and Trichohyalin. We observed thin and faint immunofluorescent staining pattern of both K72 and Trichohyalin in IRS of PA-PLA1 -/-mice ( Figure 5D and Supplementary Figure S7D and E). Thus, we confirmed that the morphological changes seen in the HE staining ( Figure 3A ) reflect malformation of the IRS. We examined in situ expression patterns of TACE, TGF , tyrosine-phosphorylated EGFR (p-EGFR) and PA-PLA1 in hair follicles. We found that PA-PLA1 was co-localized with TACE, TGF and p-EGFR in IRS ( Figure 4A-C) . The specificity of anti-PA-PLA1 antibody was verified using PA-PLA1 -/-hair follicles (faint fluorescent signal, Figure 3F ). Expression of P2Y5 was demonstrated in a previous report (Shimomura et al., Nat. Genet. 40, 335 (2008) ) showing that P2Y5 was exclusively expressed in the IRS. Thus, LPA-related proteins (PA-PLA1 and P2Y5) and TGFrelated proteins (TACE, TGF and p-EGFR) were co-expressed in the IRS. This strongly suggests that LPA-induced shedding of TGF and the following EGFR activation occur in the IRS.
The major conclusion is that the activation of EGFR via LPA and PA-PLA1a leads to hair follicle formation-but the hair follicles did form in the knockout mice, they just show some mild defects in the hair shaft appearance. I would change the title to reflect the defect in the IRS -maybe use instead of "formation" "proper hair follicle differentiation", or something about the hair shaft molding. Impaired "formation" would mean the entire hair follicles with bulges and bulbs were missing from the dermis.
As pointed out by the Referee #3's comment, impaired hair follicles were indeed formed in PA-PLA1 -/-mice. Thus, we deleted the word "formation" from the title and replaced it with the word "development." We also deleted the word "formation" in the abstract and used "development" or "differentiation and maturation" (p. 2, line 3, 7 and 14).
Minor criticism 1. In the intro it is mentioned PA-PLA is high in hair follicle epithelial cells without a reference.
As pointed out by the Referee #3's comment, we have included two references (Kazantseva et al. 
The abstract and intro should mention that the PA-PLA1 knockout mice have been generated here in this study-this is fair to the paper and makes it clear what the contribution is.
Thank you very much for the Referee #3's comment. We have included sentence "Here we generated PA-PLA1 -deficient mice" in the abstract (p.2, line 5) and "we generated and analyzed PA-PLA1 -deficient (PA-PLA1 -/-) mice" in the introduction (p.4, line 13).
3. Data in S1C shows western with extract from stomachs-why not skin? Western blot analysis of skin extract was shown in Figure 4D of the revised manuscript, confirming that PA-PLA1 protein is missing in PA-PLA1 -/-skin. To make it clear, we added the word " Figure  4D " after "Deletion of exon 3 resulted in a frameshift mutation and no immunoreactive PA-PLA1 protein" (p.5, line 6). When equal amount of proteins of tissue lysates were examined by western blotting, stomach lysate gave the most intense signals (data not shown). In addition, clear PA-PLA1 -specific bands appear in stomach extract, compared with skin extract ( Figure 4D and Supplementary Figure S1C ). Thus we analyzed stomach extract for the initial confirmation.
"Conditioned" in figure 6A is misspelled;
Thank you very much for the Referee #3's comment. We have corrected the word ( Figure 7A ). Figure 6A is nice. Something similar should be added to Figure 1 to introduce the phospholipid system for the general audience at EMBO. According to the suggestion of the Referee #3, we added a scheme showing the phospholipid system in Figure 1A of the revised manuscript.
The scheme in
We have made all of the changes requested by the Referees and improved the presentation substantially. We believe that the revised manuscript is now acceptable for publication in the EMBO Journal, and look forward to your editorial decision.
We again thank you and the Referees for the constructive criticism and suggestions for the improvement of our work.
2nd Editorial Decision 05 May 2011
Thank you for submitting your manuscript -EMBOJ-2011-78018 -to the EMBO Journal. This is a resubmission of MS 75294 that was rejected post-review last year.
I have now had the opportunity to take a careful look at the resubmission and I am afraid that we cannot offer to reconsider the manuscript. I appreciate that you have added data support that TGFa shedding and EGFR activation is affected in the PA-PLA1a deficient mice. The added TACE kd analysis also supports a role of TACE in TGFa shedding and EGFR activation. We appreciate that this data strengthens the paper. However, the analysis also provides limited further insight into the molecular link between LPA/P2Y5 and TACE activity. In other words how does LPA/P2Y5 promote TACE dependent shedding of TGFa. TACE expression looks to be fine in the PA-PLA1a deficient mice, but is its activity affected and if so how (referee #2 point 1)? Referee #3 also found the phenotype described relative mild and felt that the advance and insight provided was not sufficient to consider publication in the EMBO Journal.
I recognize that the added data extends the previous submission, but given the original reports on the manuscript I am also afraid that we are not persuaded that the advance and insight provided is sufficient to consider publication in the EMBO Journal.
I am sorry that I cannot be more positive on this occasion, but I sincerely hope that you soon will receive more encouraging news Thank you for your response to our re-submitted manuscript.
I am writing this e-mail to ask you a chance for re-review because we think we can answer the questions and criticisms you raised.
(1) As you first pointed out, our present manuscript lacks evidence for mechanistic insight into the molecular link between LPA/P2Y5 and TACE activity.
We believe that this is a very important aspect of this study. Actually we have already examined the mechanism underlying TACE activation downstream of P2Y5 activation. We are ready to show the data in the revised manuscript. Using various inhibitors and dominant negative (DN) forms of G proteins, we have examined signal transduction that is responsible for mediating P2Y5-induced TGFa shedding in vitro. Our results suggest that Gq and G12/13 signaling pathways were responsible for LPA/P2Y5-induced TACE activation that resulted in TGFa shedding. To our knowledge, these results demonstrate the first evidence that shows G12/13 as a regulator of TACE. These analyses of intracellular signalings were not included in the revised manuscript nor in the reply to the Reviewers' comment. However, if desired, we are ready to present and include the detailed data immediately.
(2) The second point you pointed out is "TACE expression looks to be fine in the PA-PLA1a deficient mice, but is its activity affected and if so how (referee #2 point 1)?"
Our in vitro study suggested that LPA-signaling mediated by P2Y5 leads to activation of TACE. We also showed, by using a novel method to detect LPA using mass spectrometry, that LPA species, especially LPA species that potently activate P2Y5, were down-regulated in PA-PLA1a KO mice. Thus, we think that TACE activity is down-regulated because of the attenuated LPA signaling.
(3) Finally you pointed out "Referee #3 also found the phenotype described relative mild and felt that the advance and insight provided was not sufficient to consider publication in the EMBO Journal."
TACE is actually very important protease that is activated by multiple pathways. But the pathways remain to be identified. In this study we showed, by using knockout mice of LPA-generating enzyme, PA-PLA1a, that LPA-signaling mediated by P2Y5 is a critical regulator of TACE activation. This is, as highlighted in the manuscript, the first knowledge of TACE regulator in vivo. It is reasonable that our PA-PLA1a KO mice show a mild hair phenotype compared with TACE and TGFa KO mice, because, as we mentioned above, there are multiple pathways for activation of TACE. However, we believe, we could show that LPA pathway (PA-PLA1a-LPA-P2Y5) is the major regulator of TACE activation because of the similar phenotype. Moreover, our data provides the first evidence of LPA-induced EGFR transactivation in vivo, which, we believe, is a major advance in a signaling field.
Thank you in advance for reconsideration of our manuscript. We hope that our manuscript will be re-reviewed.
Additional Correspondence 11 May 2011
I appreciate your arguments and yes I will send the study out for review if you resubmit. I think it would be nice to include the data on the Gq and G12/13 signaling pathway in the resubmission. Please note that the manuscript will be considered as a new submission and that I might bring in new referee(s) if needed. Also as you are aware off I can't predict the outcome of the review process.
Kind regards Editor
The EMBO Journal As suggested by the Referee #1, we have repeatedly examined the TGF levels in the soluble fraction of hair follicles by carefully isolating vibrissa hair follicles in the presence of ADAM inhibitors (EDTA and SDZ 242-484). We found that soluble TGF level in PA-PLA1 -/-mice was approximately one third of that in WT mice ( Figure 5A ). We further performed immunofluorescent staining of p-EGFR in hair follicles. We found that p-EGFR was specifically localized to the IRS in hair follicles and that the p-EGFR level was dramatically decreased in PA-PLA1 -/-mice ( Figure 5D ). Thus, we can now show multiple evidences that TGF ectodomain shedding is decreased in PA-PLA1 -/-hair follicles. According to the Referee #1's recommendation, we have determined the amount of TGF in the insoluble fraction of hair follicle lysates. We found that the amount of the cell associated/membrane-bound form of TGF in the PA-PLA1 -/-sample was almost equal to that in WT sample (Supplementary Figure S6B) .
A related (but less fundamental) weakness, in the in vitro work, is the evidence for metalloprotease involvement in the shedding. It is not sufficient to state that the inhibitor used is "broad-spectrum", without references or data. Since the proposed model involves TACE-which is an ADAM, not an MMP (more on this below)-we need to know whether the inhibitor works against TACE. We also need assurance that this compound is not affecting TGFa release due to cytotoxicity, a common problem.
A previous report showed that the compound SDZ 242-484 inhibited the activity of TACE as well as those of MMPs (MMP-1, MMP-2 and MMP-3) at IC50 values of sub nM range in vitro (Kottirsch et al., J. Med. Chem. 45, 2289 (2002 ), this reference was included in the resubmitted manuscript (p. 10, line 20). To examine a proteinase involved in LPA-induced ectodomain shedding of TGF , we focused on TACE and performed RNAi experiments because TACE was shown to be involved in hair follicle development and ectodomain shedding of TGF (Peschon et al., Science 282, 1281 -1284 (1998 ). Transfection of TACE siRNA completely abolished LPA-induced TGF release in both HaCaT human keratinocytes and HEK293 cells ( Figure 6F and 8C), which mimicked SDZ 242-484 treatment ( Figure 6A and 8A). Thus we concluded that TACE was responsible for LPA-induced TGF shedding and that TACE activity was inhibited by SDZ 242-484. We observed that presence of SDZ 242-484 at the same concentration (10 M) used in the TGF release assay ( Figure 6A ) did not affect EGF-induced phosphorylation of EGFR and ERK in HaCaT cells ( Figure 6C ). This indicates that the effect of SDZ 242-484 on TGF release is not likely due to cytotoxicity.
3. Figure 1B shows appearance of P25 mice. To avoid confusion, "One week after birth" was deleted.
Instead, "The wavy hair phenotype was most apparent from one to four weeks of age and became less severe after the start of the anagen (growth) phase of the first hair cycle." was added (p. 5, line 14).
p. 8, first line: "the" missing between "that" and "main"
Thank you very much for the Referee #1's comment. In the preparation of the resubmitted manuscript, we have deleted the sentence.
p. 10, line 10: include the Peschon 1998 reference
As pointed out by the Referee #1's comment, we have included the reference (p. 10, line 14).
p. 12, line 6: insert "further" between "we" and "tested"
p. 13, line 3 from bottom: insert "in addition to P2Y5" between "LPA3" and "was"
p. 14, line 3: meaning of "emerging" here isn't clear
As pointed out by the Referee #1's comment, we have deleted the word "emerging" (p. 14, line 5).
p. 14, line 10: "significantly" suggests a lot, whereas in fact the differences are marginal; I would just say "decreased"
As pointed out by the Referee #1's comment, we have deleted the word "significantly" (p. 14, line 12).
p. 15, line 4 from bottom: is the result with conditioned media shown?
We did not show the result with conditioned media. Thus we have included "data not shown" after "but not the conditioned media from the cells" (p. 16, line 13).
p. 16, line 5: insert "other" between "unlike" and "lipases" As pointed out by the Referee #1's comment, we have corrected the sentence (p. 16, line 22).
p. 37: isn't 10 M an unphysiologically high concentration?
As the Referee #1 noted, 10 M of LPA in the conditioned media seems to be an unphysiologically high concentration. From LC-MS/MS analysis, we estimated LPA concentration in hair follicles as follows. LC-MS/MS data ( Figure 2A) showed that a single mouse vibrissa hair follicle contained approximately 0.12 pmol LPA that was produced by PA-PLA1 . Volume of mouse vibrissa hair follicle is approximately 0.6 mm3 (0.2 x 0.2 x 1.5 mm). Morphologically, the ratio of IRS volume to hair follicle is at most one fifth (see Supplementary Figure S4 ). We estimated that extracellular space is at most one tenth of total IRS volume (IRS is packed with cells). Taken together, concentration of LPA in IRS can be speculated around 10 M (0.12 pmol / 0.6 mm3 x 5 x 10). We also note that more than 10 M of LPA can be detected in serum and incubated plasma (Aoki et al., J. Biol. Chem. 277, 48737 (2002) ).
p. 40, line 5: I would say "one" instead of "either"
Fig. 8C: how many cells were used? (so a comparison with Fig. 8B can be made)
In Figure 8C , 2 x 103 PA-PLA1 -expressing cells were added in each well. Thus we have included "2 x 103 PA-PLA1 -expressing cells per well" in the legend of the Figure 9 (p. 35, line 11). According to the Referee #2's recommendation, we have quantified the expression levels of eight ADAM members that possess catalytic activities (Edwards et al., Mol. Aspects Med. 29, 258 (2008) ). We found that there were no differences in the expression of eight ADAM members between WT and PA-PLA1 -/-hair follicles (Supplementary Figure S6C) . We also performed immunofluorescent staining of TACE in hair follicles. This analysis also showed no apparent difference in the expression pattern and expression level between WT and PA-PLA1 -/-hair follicles (Supplementary Figure S7A) . Among ADAM members, wavy hair phenotype is observed only in TACE-deficient mice. In addition, TGF was shown to be a substrate for TACE (Peschon et al., Science 282, 1281 -1284 (1998 Edwards et al., Mol. Aspects Med. 29, 258 (2008) ). Thus, we focused on TACE and performed RNAi experiments. Transfection of TACE siRNA completely abolished LPA-induced TGF release in both HaCaT human keratinocytes and HEK293 cells ( Figure 6F and 8C). Thus we concluded that TACE is responsible for TGF cleavage in response to LPA. Furthermore, we examined signaling pathway mediating LPA/P2Y5-induced TGF cleavage. We found that a G12/13-RhoA-ROCK pathway mediates LPA/P2Y5-induced TGF cleavage ( Figure 8D-F) , demonstrating a novel pathway involved in TACE activation.
Does LPA administration induce the release of other EGFR ligands besides TGFa We have examined release of other EGFR ligands (heparin-binding EGF-like growth factor (HB-EGF) and Amphiregulin).
We transfected alkaline-phosphatase-tagged EGFR ligands (AP-TGF , AP-HB-EGF or APAmphiregulin; Tokumaru et al., J. Cell Biol. 151, 209 (2000) ) in combination with P2Y5 into HEK293 cells and stimulated these cells with LPA. Compared with TGF , neither HB-EGF nor Amphiregulin was released from the transfected HEK293 cells upon LPA treatment (Supplementary Figure S10A) . Thus we concluded that LPA/P2Y5-induced EGFR ligand release is specific to TGF .
Is the phosphorylation status of EGFR altered in situ in hair follicles from PA-PLA1a-/-mice? Is P2Y5 expressed in the same cells? We examined phosphorylation status of EGFR (p-EGFR) in hair follicles by immunofluorescence using antibody that specifically recognizes p-Tyr 1068 of EGFR.
We found that (i) p-EGFR signal was significantly decreased in PA-PLA1 -/-hair follicle than WT hair follicle ( Figure 5D ) and (ii) p-EGFR was co-localized with PA-PLA1 ( Figure 4C ) and K72 (IRS marker; Figure 5D ). Expression of P2Y5 was demonstrated in a previous report (Shimomura et al., Nat. Genet. 40, 335 (2008) ) showing that P2Y5 was exclusively expressed in the IRS. Thus, LPA-producing enzyme (PA-PLA1 ), LPA receptor (P2Y5) and p-EGFR are co-localized in the IRS. These data strongly suggest that LPA-induced shedding of TGF and the following EGFR activation occur in the IRS.
Figure 5C: Why does LPA at 1 M induce EGFR phosphorylation in the presence of MMP inhibitors? The statement "LPA also induced a dramatic increase in the level of phosphorylated EGFR at Tyr1068 (p-EGFR)" is exaggerated. As pointed out by the Referee #2, it seems that 1 M LPA in the presence of MMP inhibitor did not completely inhibited LPA-induced phosphorylation of EGFR.
We repeated same experiments in three more times and found that the MMP inhibitor attenuated LPA-induced phosphorylation of EGFR. We replaced the previous image with another representative image ( Figure 6C ). As pointed out by the Referee #2, LPA-induced phosphorylation of EGFR was significant, but small as compared with EGF stimulation. Thus we have deleted the word "dramatic" from the sentence (p. 10, line 24). Figure 4B: The statement "Among eight LPA species examined, five of six unsaturated LPA species (18:2, 18:1, 20:5, 20:4 and 22:6) were decreased in PA-PLA1a-/-mice, whereas saturated LPA species (16:0 and 18:0) were unchanged" is incorrect as LPA 16:0 is also significantly decreased in PA-PLA1a-/-mice.
5.
As pointed out by the Referee #2, we have corrected the sentence. In the resubmitted manuscript, we described "Among eight LPA species examined, five of six unsaturated LPA species (18:2, 18:1, 20:5, 20:4 and 22:6) were significantly reduced in both skin and hair follicles of PA-PLA1 -/-mice ( Figure 2A and Supplementary Figure S3B) . Notably, in hair follicle of PA-PLA1 -/-mice, the six unsaturated LPA species were reduced by more than 90%, whereas saturated LPA species were unchanged (18:0) or slightly decreased (16:0) (Figure 2A )." (from p. 6, line 10 to line 14). Fig. 3B,C As pointed out by the Referee #2, we misunderstood that hair follicle morphogenesis is the first hair cycle. In the resubmitted manuscript, we have carefully checked words and used the word "morphogenesis" (legend of the Figure 4F etc.). Fig. S4 As pointed out by the Referee #2, we have included statistical analysis (Supplementary Figure S2 and the corresponding legend).
The labelling in

Statistical analysis is missing in
Referee #3 (Remarks to the Author): Figure 2B&C show clear defects in the molding of the hair shaft. Figure S2A , S2C and 1A not convincing-maybe move S2B in Figure 1A next According to the Referee #3's suggestion, we have moved the original Figure S2B showing wavy hair in Figure 1 (the image is now numbered as Figure 1D ). We have obtained more than three hundreds of PA-PLA1 -/-mice so far and all of them showed wavy hair phenotype. Thus, we have included the sentence "The hair abnormalities were observed in all PA-PLA1 -/-mice (more than 300 animals observed), …" in the resubmitted manuscript (p. 5, line 11). In case of serial sections stained with HE, three pairs of littermates (at least four vibrissa hair follicles per an individual mouse) were examined and irregular IRS morphology was only observed in PA-PLA1 -/-hair follicles. For other cases, numbers of animals examined or numbers of independent analyses were written in the legends.
Major criticism 1. The curly hair phenotype was not documented convincingly, although data in
Where exactly is the PA-PLA1alpha gene expressed in the hair follicle epithelial cells? The mRNA in situ is not necessarily convincing. Can the authors perform antibody staining and colocalization of with other hair markers in wild type and knockout mice?
We performed immunofluorescent staining of PA-PLA1 using an enhanced sensitivity method (TSA system kit, Invitrogen) and successfully detected PA-PLA1 protein in hair follicles ( Figure  3F ). Among layer-specific markers, PA-PLA1 was co-localized with the IRS marker (K72) and the companion layer marker (K75) ( Figure 3G and H). We also performed immunostaining of hair follicle markers in PA-PLA1 -/-mice. We found that thin and faint immunofluorescent staining for IRS marker (K72 and Trichohyalin) in IRS of PA-PLA1 -/-hair follicles, but unchanged immunofluorescent staining for other layer-specific markers ( Figure 5D and Supplementary Figure  S7A -E).
In figure 1 -the authors should add immunofluorescence staining for the IRS-the defects in IRS are not clear and the H&E although suggesting does not provide sufficient information to document the phenotype-
According to the suggestion of the Referee #3, we performed immunofluorescent staining for IRS using antibodies against K72 and Trichohyalin. Immunofluorescent signals of both K72 ( Figure 5D ) and Trichohyalin (Supplementary Figure S7D and E) were thinner and less intense in PA-PLA1 -/-hair follicles than in WT hair follicles. Thus, we confirmed that the morphological changes seen in the HE staining ( Figure 3A) reflect malformation of the IRS in PA-PLA1 -/-hair follicles. We examined in situ expression patterns of TACE, TGF , tyrosine-phosphorylated EGFR (p-EGFR) and PA-PLA1 in hair follicles. We found that PA-PLA1 was co-localized with TACE, TGF and p-EGFR in IRS ( Figure 4A-C) . The specificity of anti-PA-PLA1 antibody was verified using PA-PLA1 -/-hair follicles (faint fluorescent signal, Figure 3F) . Expression of P2Y5 was demonstrated in a previous report (Shimomura et al., Nat. Genet. 40, 335 (2008) ) showing that P2Y5 was exclusively expressed in the IRS. Thus, LPA-related proteins (PA-PLA1 and P2Y5) and TGFrelated proteins (TACE, TGF and p-EGFR) were co-expressed in the IRS. This strongly suggests that LPA-induced shedding of TGF and the following EGFR activation occur in the IRS. As pointed out by the Referee #3's comment, impaired hair follicles were indeed formed in PA-PLA1 -/-mice. Thus, we deleted the word "formation" from the title and replaced it with the word "development." We also deleted the word "formation" in the abstract and instead used "development" (p. 2, line 3 and 7) or "differentiation and maturation" (p. 2, line 14).
When referring to "expression
The major conclusion is that the activation of EGFR via
Minor criticism 1. In the intro it is mentioned PA-PLA is high in hair follicle epithelial cells without a reference.
The abstract and intro should mention that the PA-PLA1 knockout mice have been generated here in this study-this is fair to the paper and makes it clear what the contribution is.
3. Data in S1C shows western with extract from stomachs-why not skin? Western blot analysis of skin extract was shown in Figure 4D of the resubmitted manuscript, confirming that PA-PLA1 protein is missing in PA-PLA1 -/-skin. To make it clear, we added the word " Figure 4D " after "Deletion of exon 3 resulted in a frameshift mutation and no immunoreactive PA-PLA1 protein" (p.5, line 6). When equal amount of proteins of tissue lysates were examined by western blotting, stomach lysate gave the most intense signals (data not shown). In addition, clear PA-PLA1 -specific bands appear in stomach extract, compared with skin extract ( Figure 4D and Supplementary Figure  S1C ). Thus we analyzed stomach extract for the initial confirmation.
"Conditioned" in figure 6A is misspelled;
Thank you very much for the Referee #3's comment. We have corrected the word ( Figure 7A ). Figure 6A is nice. Something similar should be added to Figure 1 to introduce the phospholipid system for the general audience at EMBO.
The scheme in
According to the suggestion of the Referee #3, we added a scheme showing the phospholipid system in Figure 1A of the resubmitted manuscript. We again thank you and the Referees for the constructive criticism and suggestions for the improvement of our work. Sincerely yours, Junken Aoki Professor Tohoku University Enclosures 3rd Editorial Decision 14 July 2011
Thank you for submitting your manuscript to the EMBO Journal. This manuscript is a resubmission of MS # 75294 that was rejected post review last year. The manuscript has now been re-reviewed by the original referees #1 and 2 and their comments are provided below. I am sorry for the delay in getting back to you, but it has unfortunately taken a little bit longer than anticipated to get the reports back.
As you can see below, both referees appreciate the added data and support publication here. They have a few minor concerns remaining, mostly involving text changes, which should not involve too much additional work to address. I would therefore ask you to submit a revised version. Once we receive the revision we will proceed with its acceptance.
Thank you for submitting your manuscript to the EMBO Journal.
Yours sincerely, Editor The EMBO Journal _____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
As stated in my assessment of the original submission of this work, it substantially advances our understanding of hair follicle formation at the molecular level and our knowledge of the lysophosphatidic acid (LPA) signaling pathway. Key in vivo findings that I summarized before were the hair phenotype of the PA-PLA1 knockout mice, localization of the malformation to the inner root sheath (IRS), and reduced LPA levels in the hair follicles. The new manuscript is substantially strengthened by showing the localization of the enzyme within the IRS and demonstrating that it colocalizes with TACE, TGF , and phospho-EGFR. Moreover, the evidence that soluble TGF and phospho-EGFR are decreased in the knockout IRS is more convincing than before. These molecular data, given previous demonstrations that LPA can induce the shedding of EGFR ligands and hence "transactivate" the EGFR, strongly suggest that normal hair follicle formation requires generation of LPA, LPA-induced TGF shedding, and consequent EGFR activation. The remainder of the work reported, employing cell systems, shows that all the steps in the proposed pathway can occur in vitro, and adds important information on the specifics of what forms of LPA and which receptors are involved. The evidence for the role of TACE and the P2Y5 LPA receptor in LPA-induced TGF shedding in HaCaT cells has been strengthened by knock-down data, and there is more detail regarding the intra-cellular signaling pathways involved. While previous work already suggested a role for LPA in hair development, and the ability of LPA to transactivate the EGFR was wellestablished, this paper ties the two phenomenological sets of observations together in vivo for the first time, revealing the molecular underpinnings of an apparently universal feature of mammalian biology.
Specific comments
The authors have met all my major concerns with the first submission. The following are minor issues: p. 2: I would remove, or change, the word "presumed" in the first sentence of the abstract. According to the introduction, it's established that PA-PLA1 does generate LPA and that P2Y5 is a LPA receptor.
p. 10: five lines from the bottom, should be Figure 6A , not 6B p. 15: Whether ADAMs are regulated through phosphorylation of their cytoplasmic domains is actually controversial, despite many papers making this claim. See J. Cell Science 123, 3913 (2010). It's OK to keep the sentence "Activity of ADAMs is regulated . . ." but I would add at the end "in some systems." p. 15: eight lines from the bottom, should be "an", not "as" p. 16: three lines from top, take out "more strongly" or "more potently"-you don't need both Fig. 3I : what do the right-most panels show?
Referee #2 (Remarks to the Author):
The manuscript has substantially improved, new data have been included and the results are more convincing supporting the proposed hypotheses. The authors present some evidence of a novel pathway controling TACE activity (G12/13-RhoA-ROCK pathway)which is a very interesting finding.
Minor issue: The paper seems to be a bit long, with many figures (10 in total!). A shorter version would be more appropriate.
1st Revision -authors' response 15 July 2011
Thank you very much for your e-mail dated on July 14, 2011, with respect to our manuscript (Tracking number EMBOJ-2011-78221 (Inoue et al., "LPA-producing enzyme PA-PLA1 regulates hair follicle development by modulating EGFR signaling"). We are pleased to know that you and the referees support publication of our work in The EMBO Journal. According to the Referee #2's suggestion, we have simplified and rearranged figures (i.e., we moved the original Figure 7C to Supplementary Figure S8A ; we merged the original Figure 6 and the original Figure 7 into " Figure 6 " in the revised manuscript; we also merged the original Figure 8 and the original Figure9 into " Figure 7 " in the revised manuscript). Followings are our point-by-point responses to the comments raised by the two Referees. 
Fig. 3I: what do the right-most panels show?
As pointed out by the Referee #1's comment, we have included the following sentence explaining the right-most panels in the legend of Figure 3 (p. 34, line 24): "Left panels, longitudinal sections of hair follicles; middle panels, enlarged images of the boxed areas in the left panels; right panels, cross sections of hair follicles."
Referee #2:
The paper seems to be a bit long, with many figures (10 in total!). A shorter version would be more appropriate.
According to the Referee #2's suggestion, we have simplified and rearranged figures. We have moved the original Figure 7C (dose-response curves) into Supplementary Figure S8 and replaced it with a simplified figure (endpoint data; Figure 6C ; figure numbers were rearranged as described below). We have deleted the original Supplementary Figure S3 , showing lysophospholipid analysis of dorsal skin with an LC-MS/MS method, due to limits of supplementary figures (upto ten supplementary figures). We have merged the original Figure 6 and the original Figure 7 into " Figure  6 " in the revised manuscript. We have also merged the original Figure 8 and the original Figure 9 into " Figure 7 " in the revised manuscript. We now have eight figures in the revised manuscript without compromising the results. We again thank you and the Referees for the constructive criticism and suggestions for the improvement of our work.
